Implementing a multisymptom chemotherapy risk assessment tool in two community oncology practices

Community Oncology

Volumn 4, Issue 6, 2007, Pages 404-409

  Hwa, Charlotte ^a   Ricci, Angela ^a   Fortenbaugh, Cathy ^b   Fallon, Jill ^c,e   Johnston, Robin ^c   Leahy, Nancy ^d  

^a Pennsylvania Oncology Hematology Associates   (United States)

^b Capital Health System   (United States)

^c Eastern Connecticut Hematology and Oncology Associates   (United States)

^d ALBERT EINSTEIN CANCER CENTER   (United States)

^e Nursing Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANEMIA; ANXIETY; CANCER; CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMMUNITY CARE; CONSTIPATION; DEPRESSION; HUMAN; NAUSEA; NEUTROPENIA; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SYMPTOMATOLOGY; VOMITING;

EID: 34250893179     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70148-6     Document Type: Review

References (9)

1. Fallon J, Fortenbaugh C. Using the AIM Higher process to implement a multisymptom prechemotherapy risk assessment tool. Poster presented at the Oncology Nursing Society 31st Annual Congress; May 4-7, 2006; Boston, Mass.
2. Quargnenti A. Chemotherapy side effects: developing a risk assessment tool for use with patients prior to their first cycle of chemotherapy. Paper presented at the Oncology Nursing Society 30th Annual Congress; April 28-May 1, 2005; Orlando, Fla.
3. Ropka ME, Padilla G, Gillespie TW. Risk modeling: applying evidence-based risk assessment in oncology nursing practice. Oncol Nurs Forum 2005; 32:49-56.
4. Moore K. Nurses improving practice: champions of success in symptom management. Continuing education monograph for oncology nurses. Pittsburgh, Pa: OES; 2005.
5. Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 1999;17:2971-2994.
6. Anonymous. The periodic health examination. Canadian task force on the periodic health examination. Can Med Assoc J 1979;121:1193-1254.
7. Quargnenti A, Krawchuk C, Fallon J, Fortenbaugh C. AIM Higher tool identifies patients at risk for neutropenia. Special Interest Group Newsletter February 2006. Available at: http://onsopcontent.ons.org/publications/ SIGNewsletters/neutro/neutro4.1.html. Accessed November 30, 2006.
8. White N, Maxwell C, Michelson J, Bedell C. Protocols for managing chemotherapy-induced neutropenia in clinical oncology practices. Cancer Nurs 2005;28:62-69.
9. Leahy N, Fortenbaugh C. Implementing a multi-symptom risk assessment tool in the sarcoma population. Poster presented at the Oncology Nursing Society 31st Annual Congress; May 4-7, 2006; Boston, Mass.